Predictions
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€142.00
13.12.20
13.12.20
€170.00
13.12.21
13.12.21
9.00%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Incyte Corp.
Start price
Target price
Perf. (%)
€67.64
24.02.21
24.02.21
-
24.02.22
24.02.22
-12.39%
25.11.21
25.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.80
23.11.20
23.11.20
€555.00
23.11.21
23.11.21
29.97%
24.11.21
24.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€500.00
22.11.21
22.11.21
7.75%
23.11.21
23.11.21
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.40
18.11.20
18.11.20
-
18.11.21
18.11.21
45.06%
19.11.21
19.11.21
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.35
15.03.21
15.03.21
€50.00
15.03.22
15.03.22
43.43%
09.11.21
09.11.21
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€177.98
22.10.20
22.10.20
€170.00
04.11.21
04.11.21
-6.03%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€406.60
22.10.20
22.10.20
€580.00
04.11.21
04.11.21
37.09%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Abbott Laboratories
Start price
Target price
Perf. (%)
€85.17
14.08.20
14.08.20
€120.00
04.11.21
04.11.21
31.44%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Baxter International
Start price
Target price
Perf. (%)
€77.61
01.07.20
01.07.20
€80.00
04.11.21
04.11.21
-12.10%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.87
08.06.20
08.06.20
€65.00
04.11.21
04.11.21
-18.67%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€131.66
06.06.20
06.06.20
€205.00
04.11.21
04.11.21
77.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.59
03.05.20
03.05.20
€90.00
04.11.21
04.11.21
-25.71%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€76.31
30.04.20
30.04.20
€55.00
04.11.21
04.11.21
-24.47%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.15
29.04.20
29.04.20
€90.00
04.11.21
04.11.21
-25.29%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€72.99
24.04.20
24.04.20
€85.00
04.11.21
04.11.21
-21.03%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€78.80
19.04.20
19.04.20
€80.00
04.11.21
04.11.21
-26.85%
05.11.21
05.11.21
Pfizer Inc.
Start price
Target price
Perf. (%)
€27.04
17.03.20
17.03.20
€33.21
04.11.21
04.11.21
47.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€70.50
12.03.20
12.03.20
€145.00
04.11.21
04.11.21
119.55%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€117.78
11.03.20
11.03.20
€150.00
04.11.21
04.11.21
20.58%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€127.44
17.01.20
17.01.20
€160.00
04.11.21
04.11.21
83.69%
05.11.21
05.11.21
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.00
22.12.19
22.12.19
€79.00
04.11.21
04.11.21
-3.61%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group